Basics Marker Therapeutics, Inc. IPO Date: August 1, 2002 Sector: Healthcare Industry: Biotech Market Cap: $13.46M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.33% Avg Daily Range (30 D): $0.03 | 3.62% Avg Daily Range (90 D): $0.05 | 3.81% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): .22M Avg Daily Volume (90 D): 1.02M Trade Size Avg Trade Size (Sh.): 278 Avg Trade Size (Sh.) (30 D): 332 Avg Trade Size (Sh.) (90 D): 185 Institutional Trades Total Inst.Trades: 24 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $.92M Avg Inst. Trade (90 D): $.92M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.02M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 106.23K     News Aug 28, 2025 @ 12:00 PM Marker Therapeutics to Participate in a Fireside C... Source: Marker Therapeutics, Inc. Aug 26, 2025 @ 11:00 AM Marker Therapeutics Provides Update on Phase 1 APO... Source: Marker Therapeutics Jun 17, 2025 @ 12:00 PM Marker Therapeutics and Cellipont Bioservices Anno... Source: N/A Nov 26, 2024 @ 4:00 PM Marker Therapeutics to Present at the Citizens JMP... Source: N/A May 15, 2024 @ 8:15 PM Marker Therapeutics Reports First Quarter 2024 Fin... Source: Marker Therapeutics Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.29 $-.4 $-.42 Diluted EPS $-.29 $-.4 $-.42 Revenue $ .86M $ .35M $ 2.25M Gross Profit $ $ $ Net Income / Loss $ -4.02M $ -4.45M $ -3.84M Operating Income / Loss $ -4.26M $ -4.61M $ -3.86M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Jan 27, 2023:   1:10 Sep 16, 2016:   1:12 Feb 25, 2014:   1:100 Jul 27, 2009:   1:10 Jun 28, 2007:   2:5 Jun 08, 2001:   1:50